富血小板血漿（PRP）市場：按類型、來源、應用和地區分類

Platelet Rich Plasma Market, By Type, By Origin, By Application, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，富血小板血漿 (PRP) 市場規模將達到 7.005 億美元，到 2033 年將達到 16.379 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 12.9%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	7.05億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	12.90%	2033年市場規模預測：	16.379億美元

富血小板血漿（PRP）是從少量全血中提取的高濃度血小板。它含有多種已知的促進組織再生的生長因子。 PRP療法作為一種治療方法多種肌肉骨骼疾病（包括肌腱炎、關節損傷和關節炎）的新方法，正日益受到關注。血小板分泌的生長因子能吸引幹細胞，刺激細胞增生和分化，進而促進組織癒合。隨著運動傷害和退化性疾病的日益增多，PRP正逐漸成為一種有前景的組織修復替代療法，可取代手術和藥物治療。

市場動態

由於其再生能力，富血小板血漿（PRP）在各個治療領域得到了迅速應用，這已成為一種新興趨勢。運動醫學的發展和肌肉骨骼疾病病例的增加是推動這一市場成長的主要因素。然而，PRP治療和設備的高成本可能會阻礙其更廣泛的應用。開發價格低廉的PRP製備試劑盒蘊藏著巨大的商機。市場領先的公司正在加大研發投入，以拓展核准的臨床適應症。例如，PRP核准用於臉部回春治療，就開闢了新的應用領域。

本次調查的主要特點

本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球富血小板血漿 (PRP) 市場主要參與者的概況：公司亮點、產品系列、關鍵亮點、財務績效和策略。
本研究涵蓋的主要公司有：Arthrex, Inc.、Ester Medical、Zimmer Biomet、 Terumo Corporation、Glofinn Oy、Medira Ltd.、Regen Lab SA、CollPlant、Generex Biotechnology Corporation、Estar Technologies Ltd.、Cesca Therapeutics, Inc.、Arteriovestt Corporation Biotechnology Corporation、Estar Technologies Ltd.、Cesca Therapeutics, Inc。
透過利用本報告中提出的見解，各公司的行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球富血小板血漿 (PRP) 市場涵蓋了該行業內各種各樣的相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過利用分析全球富血小板血漿 (PRP) 市場中使用的各種策略矩陣，相關人員可以更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Arthrex, Inc.
- Ester Medical
- Zimmer Biomet
- Terumo Corporation
- Glofinn Oy
- Medira Ltd.
- Regen Lab SA
- CollPlant
- Generex Biotechnology Corporation
- Estar Technologies Ltd.
- Cesca Therapeutics, Inc.
- Arteriocyte Medical Systems
- Harvest Technologies Corp.
- EmCyte Corporation
- T-Biotechnology Ltd.
- Isto Biologics

第9章分析師觀點

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI936

Platelet Rich Plasma Market is estimated to be valued at USD 700.5 Mn in 2026 and is expected to reach USD 1,637.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 700.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	12.90%	2033 Value Projection:	USD 1,637.9 Mn

Platelet Rich Plasma (PRP) is an enriched concentration of platelets extracted from a small volume of whole blood. It contains several growth factors that are known to accelerate tissue regeneration. PRP therapy is an upcoming treatment for various musculoskeletal conditions such as tendonitis, joint injuries, and arthritis. The secretion of growth factors from platelets induces tissue healing by attracting stem cells and stimulating cell proliferation and differentiation. With the increasing prevalence of sports injuries and degenerative conditions, PRP is emerging as a promising alternative to surgical interventions and medications for tissue repair.

Market Dynamics

Recent trends indicate the rapid adoption of PRP in various therapeutic areas due to its regenerative properties. Growth in sports medicine and rising cases of musculoskeletal disorders are major drivers for this market. However, high costs associated with PRP procedures and equipment may restrain wider adoption. The development of inexpensive PRP preparation kits presents significant opportunities. Market leaders are investing in R&D to expand approved clinical indications. For example, regulatory approvals for use of PRP in facial rejuvenation opens new avenues.

Key Features of the Study

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global platelet rich plasma market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this Arthrex, Inc., Ester Medical, Zimmer Biomet, Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, Estar Technologies Ltd., Cesca Therapeutics, Inc., Arteriocyte Medical Systems, Harvest Technologies Corp., EmCyte Corporation, T-Biotechnology Ltd., and Isto Biologics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global platelet rich plasma market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global platelet rich plasma market.

Market Segmentation

Type Insights (Revenue, USD Mn, 2021 - 2033)
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
Origin Insights (Revenue, USD Mn, 2021 - 2033)
Autologous
Allogenic
Homologues
Application Insights (Revenue, USD Mn, 2021 - 2033)
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Arthrex, Inc.
Ester Medical
Zimmer Biomet
Terumo Corporation
Glofinn Oy
Medira Ltd.
Regen Lab S.A.
CollPlant
Generex Biotechnology Corporation
Estar Technologies Ltd.
Cesca Therapeutics, Inc.
Arteriocyte Medical Systems
Harvest Technologies Corp.
EmCyte Corporation
T-Biotechnology Ltd.
Isto Biologics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Origin
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Platelet Rich Plasma Market, By Type, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Pure PRP
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Leukocyte rich PRP
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Pure PRF
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Leukocyte rich PRF
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Platelet Rich Plasma Market, By Origin, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Autologous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Allogenic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Homologues
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Platelet Rich Plasma Market, By Application, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Neurosurgery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Cosmetic Surgery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Orthopedic Surgery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
General Surgery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Platelet Rich Plasma Market, By Region, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Arthrex, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ester Medical
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Zimmer Biomet
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Terumo Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Glofinn Oy
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Medira Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Regen Lab S.A.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- CollPlant
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Generex Biotechnology Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Estar Technologies Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cesca Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Arteriocyte Medical Systems
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Harvest Technologies Corp.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- EmCyte Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- T-Biotechnology Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Isto Biologics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies